TY - JOUR
KW - Cardiovascular disease
KW - chronic obstructive pulmonary disease
KW - Electronic Health Records
KW - epidemiology
AU - E. Graul
AU - C. Nordon
AU - K. Rhodes
AU - J. Marshall
AU - S. Menon
AU - C. Kallis
AU - A. Ioannides
AU - H. Whittaker
AU - N. Peters
AU - J. Quint
AD - Imperial College London School of Public Health, 156430, London, GB, United Kingdom of Great Britain and Northern Ireland.
AstraZeneca UK Limited, 4978, Cambridge, United Kingdom of Great Britain and Northern Ireland.
AstraZeneca UK Limited, 4978, London, United Kingdom of Great Britain and Northern Ireland.
Imperial College London School of Public Health, 156430, London, United Kingdom of Great Britain and Northern Ireland.
Imperial College London National Heart and Lung Institute, 90897, London, United Kingdom of Great Britain and Northern Ireland.
Imperial College London National Heart and Lung Institute, 90897, London, United Kingdom of Great Britain and Northern Ireland; j.quint@imperial.ac.uk.
AN - 38127850
BT - Am J Respir Crit Care Med
DO - 10.1164/rccm.202307-1122OC
DP - NLM
ET - 2023/12/21
LA - eng
N1 - 1535-4970
Graul, Emily L
Orcid: 0000-0003-4717-0907
Nordon, Clementine
Rhodes, Kirsty
Marshall, Jonathan
Menon, Shruti
Kallis, Constantinos
Ioannides, Anne E
Whittaker, Hannah R
Peters, Nicholas S
Quint, Jennifer K
Journal Article
United States
Am J Respir Crit Care Med. 2023 Dec 21. doi: 10.1164/rccm.202307-1122OC.
PY - 2023
SN - 1073-449x
T2 - Am J Respir Crit Care Med
TI - Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study
ER -